Learn More
OBJECTIVE In recent years there has been an increase in infections caused by gram-positive cocci in critical patients, together with a rapid development of resistance to the antibiotics which are(More)
The objective of this paper was to assess the cost–utility of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection (CDI) in three specific CDI patient subgroups: those(More)
comycin in the treatment of adult CDI patients. The analysis focused on three CDI patient subgroups: cancer, concomitant antimicrobials, and renal impaired patients. Methods: A Markov model was(More)